Galera Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Sorensen Mel | President and CEO | Sale | 70,000 | $0.02 | $1,400 | 195,029 | Nov 20, 2025 |
| CHANG NANCY T | — | Purchase | 7,644,932 | $0.07 | $535,145 | 7,644,932 | Dec 30, 2024 |
| Sorensen Mel | President and CEO | Sale | 67,015 | $0.07 | $4,691 | 265,029 | Aug 16, 2024 |
| Schneid Yair | — | Purchase | 4,245 | $0.20 | $849 | 10,645,066 | Apr 18, 2024 |
| Altamont Pharmaceutical Holdings, LLC | — | Sale | 400,000 | $0.23 | $92,000 | 4,880,000 | Mar 28, 2024 |
| Schneid Yair | — | Purchase | 150,000 | $0.18 | $27,000 | 7,260,801 | Feb 7, 2024 |
| Bachleda Mark | Chief Commercial Officer | Purchase | 11,000 | $2.25 | $24,750 | 11,000 | Mar 16, 2023 |
| Degnan Chris | Chief Financial Officer | Purchase | 10,000 | $1.96 | $19,600 | 10,000 | Mar 13, 2023 |
| Sorensen Mel | President and CEO | Purchase | 100,000 | $1.68 | $168,000 | 332,044 | Mar 10, 2023 |
| Beardsley Robert A | Chief Operating Officer | Option Exercise | 10,000 | $1.07 | $10,700 | 108,191 | Nov 21, 2022 |
| Beardsley Robert A | Chief Operating Officer | Option Exercise | 10,000 | $1.07 | $10,700 | 98,191 | Sep 12, 2022 |
| Alleva Lawrence M | — | Gift | 4,000 | — | — | 2,325 | Jul 18, 2022 |
| West Linda | — | Purchase | 20,000 | $2.74 | $54,800 | 60,000 | Dec 17, 2021 |
| Beardsley Robert A | Chief Operating Officer | Option Exercise | 20,000 | $1.07 | $21,400 | 88,191 | Dec 17, 2021 |
| HOLMLUND JON T | Chief Medical Officer | Option Exercise | 47,756 | $2.43 | $116,047 | 47,756 | Sep 1, 2021 |
| West Linda | — | Purchase | 10,000 | $9.13 | $91,300 | 40,000 | Jun 15, 2021 |
| West Linda | — | Purchase | 10,000 | $8.65 | $86,500 | 30,000 | Jun 2, 2021 |
| Alleva Lawrence M | — | Purchase | 4,045 | $8.59 | $34,747 | 4,045 | Jun 1, 2021 |
| West Linda | — | Purchase | 10,000 | $8.64 | $86,400 | 10,000 | Jun 1, 2021 |
| Sorensen Mel | President and CEO | Option Exercise | 46,940 | $1.14 | $53,512 | 232,044 | Mar 26, 2021 |
| Novo Holdings A/S | — | Sale | 500,000 | $10.58 | $5,290,000 | 2,459,021 | Feb 18, 2021 |
| Alleva Lawrence M | — | Purchase | 2,325 | $10.22 | $23,762 | 6,325 | Nov 13, 2020 |
| Sussman Joel F. | Chief Accounting Officer | Sale | 10,000 | $10.32 | $103,200 | — | Nov 13, 2020 |
| HOLMLUND JON T | Chief Medical Officer | Sale | 2,244 | $15.00 | $33,660 | — | Oct 26, 2020 |
| Novo Holdings A/S | — | Sale | 450,000 | $11.00 | $4,950,000 | 2,959,021 | Oct 15, 2020 |
| HOLMLUND JON T | Chief Medical Officer | Sale | 10,536 | $12.00 | $126,432 | — | Oct 5, 2020 |
| Novartis Bioventures Ltd | — | Sale | 900 | $9.04 | $8,136 | 3,469,273 | Jun 19, 2020 |
| NOVARTIS AG | — | Sale | 4,622 | $9.27 | $42,846 | 3,470,173 | Jun 15, 2020 |
| NOVARTIS AG | — | Sale | 8,532 | $9.46 | $80,713 | 3,498,259 | Jun 12, 2020 |
| Novartis Bioventures Ltd | — | Sale | 5,659 | $9.66 | $54,666 | 3,513,791 | Jun 5, 2020 |
| Novartis Bioventures Ltd | — | Sale | 5,208 | $9.78 | $50,934 | 3,532,190 | Jun 4, 2020 |
| HOLMLUND JON T | Chief Medical Officer | Option Exercise | 692 | $1.07 | $740 | 692 | May 26, 2020 |
| HOLMLUND JON T | Chief Medical Officer | Sale | 969 | $12.00 | $11,628 | — | May 21, 2020 |
| HOLMLUND JON T | Chief Medical Officer | Option Exercise | 185 | $1.07 | $198 | 185 | May 8, 2020 |
| HOLMLUND JON T | Chief Medical Officer | Sale | 3,064 | $12.16 | $37,258 | — | May 5, 2020 |
| Alleva Lawrence M | — | Purchase | 4,000 | $9.78 | $39,120 | 4,000 | Dec 13, 2019 |
| Clarus IV-B, L.P. | — | C | 555,193 | — | — | 555,193 | Nov 12, 2019 |
| Blackstone Holdings II L.P. | — | C | 301,001 | — | — | 301,001 | Nov 12, 2019 |
| Novo Holdings A/S | — | C | 535,869 | — | — | 2,909,021 | Nov 12, 2019 |
| MOTT DAVID M | — | C | 267,935 | — | — | 3,941,381 | Nov 12, 2019 |
| HEALY JAMES | — | Purchase | 750,000 | $12.00 | $9,000,000 | 3,083,712 | Nov 12, 2019 |
| NOVARTIS AG | — | Purchase | 250,000 | $12.00 | $3,000,000 | 3,543,067 | Nov 12, 2019 |
| Beardsley Robert A | Chief Operating Officer | C | 15,361 | — | — | 68,191 | Nov 12, 2019 |